Class I recall for Siemens bacterial infection tests

Siemens Healthcare Diagnostics' Rapid Gram Negative Combo Panels measuring bacteria to determine antibiotic treatment are under a Class I recall from the FDA. The agency said the tests, which are meant to identify certain gram negative bacteria and measure how these bacteria respond to antibiotics to help healthcare providers select the correct treatment for a patient, are inaccurately reporting certain bacteria as sensitive to certain antibiotics when they are in fact resistant. The incorrect test results relate to these antibiotics: Aztreonam, Cefotaxime, Ceftazidime, and Ceftriaxone. The tests were recalled because they can cause ineffective treatment and, in rare instances, may contribute to death. Safety Alert

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.